CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Revenue:
Patient revenue	$ 469,000	$ 548,000	$ 1,064,000	$ 1,044,000
Expenses:
Patient expenses	220,000	149,000	426,000	327,000
Selling, general and administrative	210,000	226,000	488,000	488,000
Total	430,000	375,000	914,000	815,000
Operating income	39,000	173,000	150,000	229,000
Income from investment in unconsolidated entities	6,000	0
Interest expense	(57,000)	(67,000)	(116,000)	(136,000)
Gain from sales of investments in unconsolidated entities			24,000	0
Loss from invesment in unconsolidated entities			(15,000)	0
Interest income	1,000	0	8,000	0
Income from continuing operations			51,000	93,000
Discontinued operations
Impairment loss			0	(89,000)
Gain from operations			0	28,000
Gain (loss) from discontinued operations			0	(61,000)
Net income (loss)	$ (11,000)	$ 106,000	$ 51,000	$ 32,000
Basic and diluted income per share (in dollars per share)	$ 0.00	$ 0.01	$ 0.01	$ 0.01
Net income per common share from continuing operations - basic and diluted (in dollars per share)			$ 0	$ (0.01)
Net loss per common share from discontinued operations - basic and diluted (in dollars per share)			$ 0.01	$ 0.00
Weighted average common shares outstanding (in shares)	7,797,185	7,747,185	7,797,185	7,747,185